High filamin-C expression predicts enhanced invasiveness and poor outcome in glioblastoma multiforme.
Muhammad KamilYoshinari ShinsatoNayuta HigaTakuro HiranoMasashi IdogawaTomoko TakajoKentaro MinamiMichiko ShimokawaMasatatsu YamamotoKohichi KawaharaHajime YonezawaHirofumi HiranoTatsuhiko FurukawaKoji YoshimotoKazunori AritaPublished in: British journal of cancer (2019)
FLNC is a potential therapeutic target and biomarker for GBM progression.